<code id='649EEC34E1'></code><style id='649EEC34E1'></style>
    • <acronym id='649EEC34E1'></acronym>
      <center id='649EEC34E1'><center id='649EEC34E1'><tfoot id='649EEC34E1'></tfoot></center><abbr id='649EEC34E1'><dir id='649EEC34E1'><tfoot id='649EEC34E1'></tfoot><noframes id='649EEC34E1'>

    • <optgroup id='649EEC34E1'><strike id='649EEC34E1'><sup id='649EEC34E1'></sup></strike><code id='649EEC34E1'></code></optgroup>
        1. <b id='649EEC34E1'><label id='649EEC34E1'><select id='649EEC34E1'><dt id='649EEC34E1'><span id='649EEC34E1'></span></dt></select></label></b><u id='649EEC34E1'></u>
          <i id='649EEC34E1'><strike id='649EEC34E1'><tt id='649EEC34E1'><pre id='649EEC34E1'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:2
          The cost of healthcare health technology assessment
          APStock

          Physicians are in line to absorb more Medicare cuts next year, while hospital outpatient departments and surgery centers will get billions in new revenue.

          The base figure that determines how much physicians get paid by Medicare will decrease by 3.3% for 2024, the federal government said Thursday.

          advertisement

          The cuts will not be distributed equally among all specialties. Indeed, primary care doctors, endocrinologists, nurse practitioners, and physician assistants would see their Medicare payment rates rise, on average, according to the annual payment rule. Cuts would be steepest for all types of radiologists, including interventionalists and nuclear medicine, as well as vascular surgeons.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          J&J to buy cancer drug developer Ambrx Biopharma
          J&J to buy cancer drug developer Ambrx Biopharma

          AP/RichardDrewJohnson&JohnsonsaidMondaythatitwouldpurchaseAmbrxBiopharmafornearly$2billion,picki

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Chronically ill young patients struggle to find fertility info

          AdobeIrecentlyturned25.Ishouldbetakingrisks,jet-settingwithotherBarbies,andflouncingaroundintinytops